Calculus invests in MIP Diagnostics

Nanotechnology business, MIP Diagnostics, has completed a £5.1m funding round to accelerate its global expansion. Calculus VCT is an existing investor, and is delighted to support the company with further funding in the round led by Downing Ventures, with BGF … Continued

Calculus invests £1m into Wazoku

Calculus Capital has invested £1m in Wazoku Limited, a fast-growing software-as-a-service (SaaS) business providing market-leading innovation management software to enterprise customers including John Lewis, HSBC and the Ministry of Defence. Wazoku’s mission is to enable companies to embed innovation as … Continued

Scancell’s vaccine technology featured on Sky News

The government is putting big bets on vaccines that may not work against the coronavirus, scientists have warned. Around 90% of experimental vaccines never reach the clinic because of problems in development or manufacture.But the government’s Vaccines Taskforce has invested … Continued

Open Orphan Launch Covid-19 Antibody Testing

LONDON, June 4, 2020 /PRNewswire/ — Launched on Thursday 4th June 2020, hVIVO COVID Clear Test, https://hvivo.com/covid-clear/, which is part of Open Orphan plc, https://www.openorphan.com/, is the most accurate antibody test available to UK employers, helping them to get their people back to work. Having recently secured … Continued

Calculus VCT plc Annual General Meeting

The Annual General Meeting (AGM) of Calculus VCT plc (the “Company”) will be held at 11.30am on 3 July 2020. The AGM is an important event in the Company’s corporate calendar, providing an opportunity for shareholders to meet the board … Continued